Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT06958679What this trial is testingEvaluation of SYS6005 in Patients With Advanced Malignant TumorWho this might be right forB-cell MalignanciesSolid Tumors CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Not applicableLooking for participantsNCT07133269What this trial is testingCare Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer PatientsWho this might be right forAdvanced Cancer Singapore General Hospital 770
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT01204203What this trial is testingPilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)Who this might be right forMesothelioma University of Alabama at Birmingham 8
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Early research (Phase 1)Study completedNCT00750425What this trial is testingPhase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursWho this might be right forAdvanced Solid Tumors AstraZeneca 46
Not applicableNot Yet RecruitingNCT07540468What this trial is testingSafety Evaluation of Bioactive Glass Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone TumorsWho this might be right forAdvanced CancerPain Liao Yun 8
Not applicableStudy completedNCT03595813What this trial is testingIdentifying Immune-related Biomarkers to Predict the Efficacy of Cancer ImmunotherapyWho this might be right forLung Cancer MetastaticLocally Advanced Malignant NeoplasmNon Hodgkin Lymphoma+1 more Institut Paoli-Calmettes 135
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Early research (Phase 1)Ended earlyNCT03936959What this trial is testingLY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 10
Early research (Phase 1)Study completedNCT01423903What this trial is testingPhase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced CancerWho this might be right forAdvanced Cancer Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Early research (Phase 1)Not Yet RecruitingNCT07291050What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant TumorsWho this might be right forAdvanced Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07605962What this trial is testingPhase 1/2 Study of UI-102 in Selected Advanced CancersWho this might be right forAdvanced Cancer United Immunity, co., Ltd. 140
Testing effectiveness (Phase 2)Study completedNCT00609401What this trial is testingStudy Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)Who this might be right forMetastatic DiseaseRenal Cell Carcinoma Italian Trial in Medical Oncology 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188What this trial is testingStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationWho this might be right forKRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more Novartis Pharmaceuticals 344